One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Trends in nephrology: kidney metabolism as a therapeutic target
doi : 10.1093/ndt/gfaf155
Volume 41, Issue 2, February 2026
Pulsed ultrasound activation of neural reflexes: a therapeutic strategy against AKI and inflammation?
doi : 10.1093/ndt/gfaf234
Towards carbon footprint measurement of the ERA Congress: five key strategies for greener events
doi : 10.1093/ndt/gfaf242
Natriuretic response to an acute oral potassium load in healthy individuals and patients with chronic kidney disease: a randomized controlled trial
doi : 10.1093/ndt/gfaf238
Changing from the CKD-EPI to the EKFC creatinine equation to estimate glomerular filtration rate in adults in a Northern European health system
doi : 10.1093/ndt/gfaf148
Typical and atypical ADPKD: predicted pathogenic genetic variants and population frequencies
doi : 10.1093/ndt/gfaf158
Clinical significance of focal segmental glomerulosclerosis subclassification in IgA nephropathy
doi : 10.1093/ndt/gfaf162
67 national-level factors potentially related to the incidence of kidney replacement therapy across Europe
doi : 10.1093/ndt/gfaf163
Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUS
doi : 10.1093/ndt/gfaf166
Attribute-based medicine for IgA nephropathy: risk factor constellations influence kidney prognosis
doi : 10.1093/ndt/gfaf170
Transition of patients with hereditary nephropathies from paediatric to adult care
doi : 10.1093/ndt/gfaf186
Obinutuzumab monotherapy is effective in adult patients with nephrotic syndrome and minimal change lesions
doi : 10.1093/ndt/gfaf241
C5 inhibitor attenuates cholesterol crystal embolism–induced thrombotic microangiopathy and acute kidney injury
doi : 10.1093/ndt/gfaf243
